News, Analysis & Insights on Nutrition, Supplements, and Health
President Trump implemented 50% tariffs on goods from India 10 days ago in retaliation for India’s importation of Russian oil. According to the BBC, prolonged 50% tariffs could ‘shave off’ as much as 0.8% of India’s GDP.
After a six year hiatus, the International Probiotics Association will again host its IPA DC Workshop with insights from a range of experts and stakeholders, including the U.S. FDA and Health Canada. The event is held in conjunction with the US...
On a mission to make creatine more approachable, Thorne is launching its Creatine Campaign spotlighting the supplement’s wide-ranging benefits.
Supplementation with Xeya Modern Shatavari may decrease hot flashes, fatigue and sleep disturbances for perimenopausal women, according to results of a new randomized, double-blind, placebo-controlled trial.
With data from a successful human trial hot off the press, an ongoing funding round to finance more clinical research and business development efforts, and commercial products launching later this year, Spain’s Genbioma is positioned for a...
Catch up with our weekly round-up of key news from across the Nutraverse.
A clinical study identified withanolide glycosides as the key drivers of superior bioavailability in ashwagandha (Withania somnifera) extracts.
Paid for and content provided by Ethical Naturals Inc. (ENI)
Current harvest forecasts for Oregon coast cranberries with high A-Type PAC content are good news for strong future supplies of Cranberex.
The Australian supplement market is seeing an increase in products for energy, sleep, and muscle relaxation, with ingredients like magnesium at the center of the action.
Paid for and content provided by Bonerge Lifescience
How can the 14 hallmarks of aging help to identify the connection between premature ovarian insufficiency (POI) and female menopause?
Paid for and in partnership with ADM
Health needs and science are shaping the rapidly evolving space of mood, stress and sleep, with benefits extending to women’s health. How is a new postbiotic positioned to address current unmet needs?